Sugi Predict

Sugi Predict / Compounds / SCHEMBL2247644

SCHEMBL2247644

SCHEMBL2247644

CCCCCCc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(CCCCCC)s5)s4)cc3)s2)s1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.39
▸ CYP2E1 P05181 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TRPV1 Q8NER1 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ APP P05067 3/20 0.37
▸ PRKCI P41743 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ RARB P10826 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767901 1.00 KCNH2 (0.39) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL10015617 1.00 KCNH2 (0.39) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL2768137 1.00 KCNH2 (0.39) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL5353884 1.00 KCNH2 (0.39) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL13410303 0.98 TSHR (0.39) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL4947793 0.96 KCNH2 (0.41) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL4949286 0.96 KCNH2 (0.41) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL4950539 0.96 KCNH2 (0.41) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL4949276 0.95 KCNH2 (0.40) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9
SCHEMBL14565385 0.94 HSD17B1 (0.36) KCNH2CYP2E1CYP3A4CYP2A6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943688-A1 LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS BASF SE (DE) 2008-07-16 — — EP claimed
WO-2007039575-A1 LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS BASF SE (DE) 2007-04-12 — — WO claimed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 — — US claimed
US-7199251-B2 Process for the production of linear organic thiophene-phenylene oligomers H.C. STARCK GMBH & CO. KG (DE) 2007-04-03 — — US claimed
US-20050098777-A1 Process for the production of linear organic thiophene-phenylene oligomers H.C. STARCK GMBH (DE) 2005-05-12 — — US claimed
EP-1943689-B1 ACTIVE SEMICONDUCTOR DEVICES BASF SE (DE) 2013-02-27 — — EP disclosed
US-7993959-B2 Methods for producing multiple distinct transistors from a single semiconductor THE JOHNS HOPKINS UNIVERSITY (US) 2011-08-09 — — US disclosed
US-7732812-B2 Active semiconductor devices BASF SE (DE) 2010-06-08 — — US disclosed
US-7719003-B2 Active organic semiconductor devices and methods for making the same ALCATEL-LUCENT USA INC. (US) 2010-05-18 — — US disclosed
US-7704784-B2 Semiconductor devices having regions of induced high and low conductivity, and methods of making the same LUCENT TECHNOLOGIES, INC. (US) 2010-04-27 — — US disclosed
US-7569415-B2 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. (US) 2009-08-04 — — US disclosed
US-20090020750-A1 ACTIVE SEMICONDUCTOR DEVICES BASF SE (DE) 2009-01-22 — — US disclosed
EP-1536498-A1 Devices having patterned regions of polycrystalline organic semiconductors, and methods of making the same LUCENT TECHNOLOGIES INC. (US) 2005-06-01 — — EP disclosed
US-20050110006-A1 Devices having patterned regions of polycrystalline organic semiconductors, and methods of making the same LUCENT TECHNOLOGIES, INC. (US) 2005-05-26 — — US disclosed
US-20050098777-A1 Process for the production of linear organic thiophene-phenylene oligomers H.C. STARCK GMBH (DE) 2005-05-12 — — US disclosed
US-20050093107-A1 Thin dielectric layers on substrates, and methods of making the same LUCENT TECHNOLOGIES, INC. (US) 2005-05-05 — — US disclosed
US-20050062066-A1 Semiconductor devices having regions of induced high and low conductivity, and methods of making the same LUCENT TECHNOLOGIES, INC. (US) 2005-03-24 — — US disclosed
US-6870180-B2 Organic polarizable gate transistor apparatus and method LUCENT TECHNOLOGIES INC. (US) 2005-03-22 — — US disclosed
US-20020195644-A1 Organic polarizable gate transistor apparatus and method ALCATEL-LUCENT USA INC. 2002-12-26 — — US disclosed
US-6403397-B1 Process for fabricating organic semiconductor device involving selective patterning AGERE SYSTEMS GUARDIAN CORP. 2002-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050098777-A1 Process for the production of linear organic thiophene-phenylene oligomers TYR, TEC, TYRO3 KCNH2 601/4885CYP2E1 904/4885CYP3A4 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.